Order Article Reprints
Journal: Vaccines, 2025
Volume: 13
Number: 623
Article:
Post-Marketing Surveillance of Nirsevimab: Safety Profile and Adverse Event Analysis from Spain’s 2023–2024 RSV Immunisation Campaign
Authors:
by
Pablo Estrella-Porter, Elisa Correcher-Martínez, Alejandro Orrico-Sánchez and Juan José Carreras
Link:
https://www.mdpi.com/2076-393X/13/6/623
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.